Peptide mapping techniques

A protein of Mr 55,000 in guinea pig milk lipid globule membranes appears to be similar but not identical to the bovine proteins using peptide mapping techniques and solubility in aqueous solutions as comparative criteria (Johnson et al. 1985). This protein is synthesized in a membrane-bound form and becomes progressively solubilized after incorporation into intracellular membranes (Mather et al 1984), a property shared by several other peripheral membrane proteins, e.g., the glycoprotein GP2 in the pancreas (Scheffer et aL 1980). 

El. Easley, C. W., Combinations of specific color reactions tiseful in the peptide mapping technique. Biochim. Biophys. Ada 107, 386-388 (1965). 

Peptide Mapping. Peptide mapping is an important tool for protein identif-ication, primary structure determination, the detection of posttranslational modifications, the identification of genetic variants, and the determination of glycosylation and/or disulfide sites. For these reasons, peptide mapping is widely used for quality control and for the characterization of recombinant DNA-derived products. Moreover, the high resolution of CE makes it a powerful peptide mapping technique. 

The use of the dynamic-FAB probe (see Section 4.4 above) has allowed the successful coupling of HPLC to this ionization technique but there is an upper limit, of around 5000 Da, to the mass of molecules which may be successfully ionized. Problem solving, therefore, often involves the use of chemical methods, such as enzymatic hydrolysis, to produce molecules of a size more appropriate for ionization, before applying techniques such as peptide mapping (see Section 5.3 below). 

Thannhauser, T. W., McWherter, C. A., and Scheraga, H. A., Peptide mapping of bovine pancreatic ribonuclease A by reverse-phase high-performance liquid chromatography. II. A two-dimensional technique for determination of disulfide pairings using a continuous-flow disulfide detection system, Anal. Biochem., 149, 322, 1985. 

Application of the analytical techniques discussed thus far focuses upon detection of proteinaceous impurities. A variety of additional tests are undertaken that focus upon the active substance itself. These tests aim to confirm that the presumed active substance observed by electrophoresis, HPLC, etc. is indeed the active substance, and that its primary sequence (and, to a lesser extent, higher orders of structure) conform to licensed product specification. Tests performed to verify the product identity include amino acid analysis, peptide mapping, N-terminal sequencing and spectrophotometric analyses. 

Even though the MALDI peptide mass mapping technique is very powerful, it has limitations. It requires well-separated proteins, is less sensitive than identifications based on electrospray tandem mass spectrometry, can only identify proteins whose complete sequences are available in databases, and does not produce redundant information. 

The easiest way to detect a protein modification seems to be the mass measurement of all peptides generated by enzymatic digestion. The comparison with the predicted peptide masses from the sequence of the protein identifies unmodified peptides and unexplained masses would give indications to modified peptides. Unfortunately, this is not a suitable approach in practice. In many peptide mapping experiments done with the MALDI mass mapping technique, up to 30% of the measured masses remain unexplained. This is probably due to protein contaminations from human keratins, chemical modifications introduced by gel electrophoresis and the digestion procedure, and other proteins present at low levels in the piece excised from the sodium dodecyl sulfate gel. The detection of a protein modification requires a more specific analysis. 

The primary analytical applications of RPLC in the development of biopharmaceuticals are the determination of protein purity and protein identity. Purity is established by analysis of the intact protein, and RPLC is useful in detecting the presence of protein variants, degradation products, and contaminants. Protein identity is most often established by cleavage of the protein with a site-specific protease followed by resolution of the cleavage products by RPLC. This technique, termed peptide mapping, should yield a unique pattern of product peptides for a protein that is homogeneous with respect to primary sequence. 

Although industrial laboratories shied away from the technique at first, CE is now becoming more common in these labs for a variety of analyses, including ion analysis, chiral pharmaceutical analysis, and peptide mapping [1]. With the increased prevalence of CE in industrial analytical laboratories comes the need for instrument qualification to ensure the proper functioning and performance of the instrument in order to obtain consistent, reliable, and accurate data. 

---